Literature DB >> 18454418

Osteogenesis and angiogenesis: the potential for engineering bone.

J M Kanczler1, R O C Oreffo.   

Abstract

The repair of large bone defects remains a major clinical orthopaedic challenge. Bone is a highly vascularised tissue reliant on the close spatial and temporal connection between blood vessels and bone cells to maintain skeletal integrity. Angiogenesis thus plays a pivotal role in skeletal development and bone fracture repair. Current procedures to repair bone defects and to provide structural and mechanical support include the use of grafts (autologous, allogeneic) or implants (polymeric or metallic). These approaches face significant limitations due to insufficient supply, potential disease transmission, rejection, cost and the inability to integrate with the surrounding host tissue. The engineering of bone tissue offers new therapeutic strategies to aid musculoskeletal healing. Various scaffold constructs have been employed in the development of tissue-engineered bone; however, an active blood vessel network is an essential pre-requisite for these to survive and integrate with existing host tissue. Combination therapies of stem cells and polymeric growth factor release scaffolds tailored to promote angiogenesis and osteogenesis are under evaluation and development actively to stimulate bone regeneration. An understanding of the cellular and molecular interactions of blood vessels and bone cells will enhance and aid the successful development of future vascularised bone scaffold constructs, enabling survival and integration of bioengineered bone with the host tissue. The role of angiogenic and osteogenic factors in the adaptive response and interaction of osteoblasts and endothelial cells during the multi step process of bone development and repair will be highlighted in this review, with consideration of how some of these key mechanisms can be combined with new developments in tissue engineering to enable repair and growth of skeletal fractures. Elucidation of the processes of angiogenesis, osteogenesis and tissue engineering strategies offer exciting future therapeutic opportunities for skeletal repair and regeneration in orthopaedics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18454418     DOI: 10.22203/ecm.v015a08

Source DB:  PubMed          Journal:  Eur Cell Mater        ISSN: 1473-2262            Impact factor:   3.942


  227 in total

Review 1.  Strategies for controlled delivery of growth factors and cells for bone regeneration.

Authors:  Tiffany N Vo; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2012-02-04       Impact factor: 15.470

Review 2.  Vascularized bone tissue engineering: approaches for potential improvement.

Authors:  Lonnissa H Nguyen; Nasim Annabi; Mehdi Nikkhah; Hojae Bae; Loïc Binan; Sangwon Park; Yunqing Kang; Yunzhi Yang; Ali Khademhosseini
Journal:  Tissue Eng Part B Rev       Date:  2012-09-04       Impact factor: 6.389

3.  Reciprocal induction of human dermal microvascular endothelial cells and human mesenchymal stem cells: time-dependent profile in a co-culture system.

Authors:  M S Laranjeira; M H Fernandes; F J Monteiro
Journal:  Cell Prolif       Date:  2012-05-18       Impact factor: 6.831

Review 4.  In vitro models for the evaluation of angiogenic potential in bone engineering.

Authors:  Elisabetta Cenni; Francesca Perut; Nicola Baldini
Journal:  Acta Pharmacol Sin       Date:  2010-11-01       Impact factor: 6.150

5.  Mechanical and Vascular Cues Synergistically Enhance Osteogenesis in Human Mesenchymal Stem Cells.

Authors:  Andrew J Steward; Jacqueline H Cole; Frances S Ligler; Elizabeth G Loboa
Journal:  Tissue Eng Part A       Date:  2016-07-29       Impact factor: 3.845

6.  [Correlation between vascular endothelial growth factor temporal expression and new bone formation in midpalatal suture during rapid maxillary expansion].

Authors:  Zhang Weibing; Lin Wang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2014-12

7.  In vitro study in stimulating the secretion of angiogenic growth factors of strontium-doped calcium polyphosphate for bone tissue engineering.

Authors:  Fei Liu; Xu Zhang; Xixun Yu; Yuanting Xu; Ting Feng; Dawei Ren
Journal:  J Mater Sci Mater Med       Date:  2011-02-02       Impact factor: 3.896

8.  A platelet derived growth factor delivery system for bone regeneration.

Authors:  J J Delgado; Esther Sánchez; Manuel Baro; Ricardo Reyes; Carmen Evora; Araceli Delgado
Journal:  J Mater Sci Mater Med       Date:  2012-05-11       Impact factor: 3.896

9.  Molecular imaging of expression of vascular endothelial growth factor a (VEGF a) in femoral bone grafts transplanted into living mice.

Authors:  Olga Strachna; Daniel Torrecilla; Marie K Reumann; Inna Serganova; Jihye Kim; Simone Gieschler; Adele L Boskey; Ronald G Blasberg; Philipp Mayer-Kuckuk
Journal:  Cell Transplant       Date:  2013-04-12       Impact factor: 4.064

10.  Osteogenic and angiogenic potentials of monocultured and co-cultured human-bone-marrow-derived mesenchymal stem cells and human-umbilical-vein endothelial cells on three-dimensional porous beta-tricalcium phosphate scaffold.

Authors:  Yunqing Kang; Sungwoo Kim; Monica Fahrenholtz; Ali Khademhosseini; Yunzhi Yang
Journal:  Acta Biomater       Date:  2012-08-16       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.